Sort
51,593 grants matching “hepatitis”
Integrating HCV services into HIV programs for PWID in India
$1,061,654Shruti H Mehta · Johns Hopkins University · R01 · FY2022 · AI
Establishment/Maintenance of Biomedical Research Colony
$1,061,517Thomas J. Rowell · University Of Louisiana At Lafayette · U42 · FY2010 · RR
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$1,061,357Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2024 · AA
Non-Human Primate Core (NHP Core)
$1,060,944Koen K Van Rompay · Duke University · P01 · FY2015 · AI
Role of the innate immune defenses in viral infections
$1,060,903Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Virus-host interactions in hepatocarcinogenesis
$1,060,761J.-H. James Ou · University Of Southern California · P01 · FY2009 · CA
Novel Therapies for Alcoholic Hepatitis
$1,060,741Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2014 · AA
Novel Therapies for Alcoholic Hepatitis
$1,060,741Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2015 · AA
Development of PAR2 Pepducins as a Novel NASH Treatment
$1,060,598Athan Kuliopulos · Oasis Pharmaceuticals · R44 · FY2018 · DK
Epidemiology of Oncogenic Viruses
$1,060,598Thomas R O'Brien · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Studies of HCV Infection And HCV-Host interactions
$1,060,516T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence
$1,060,516T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C
$1,060,516T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Virus-host interactions in hepatocarcinogenesis
$1,060,016J.-H. James Ou · University Of Southern California · P01 · FY2007 · CA
Epidemiologic Study of Hepatocellular Carcinoma in the US
$1,059,509Herbert Yu · University Of Hawaii At Manoa · R01 · FY2012 · CA
Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians
$1,059,022Leslie J Baier · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Studies of HCV Infection And HCV-Host interactions
$1,058,228T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C
$1,058,228T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Use Of Animal Models To Study Genes That Modulate Atherosclerosis
$1,057,935Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$1,057,333Douglas K Owens · Stanford University · R37 · FY2021 · DA
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
$1,057,149Chung-Chou Ho Chang · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL
The PIP2-virus interface and PI 4-kinase: novel biology and validation targets
$1,057,049Jeffrey S Glenn · Stanford University · R01 · FY2014 · AI
A Multi-Center Group to Study Acute Liver Failure in Children
$1,056,928Robert H Squires · Children'S Hosp Pittsburgh/Upmc Hlth Sys · U01 · FY2008 · DK
Tracking HIV Infection and Alcohol Abuse CNS Comorbidity with Neuroimaging
$1,056,910Adolf Pfefferbaum · Sri International · U01 · FY2013 · AA
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)
$1,056,107Philip Todd Korthuis · Oregon Health & Science University · U01 · FY2020 · TR